Culbertson A N & Co’s Eli Lilly LLY Stock Holding History

Culbertson A N & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	1,035 +155	+18%	+$158K	0.14%	94
2026 Q1	$809K	Hold	880	–	–	0.11%	101
2025 Q4	$946K	Hold	880	–	–	0.13%	94
2025 Q3	$671K	Buy	880 +4	+0.5%	+$2.98K	0.1%	101
2025 Q2	$683K	Buy	876 +123	+16%	+$95.6K	0.1%	101
2025 Q1	$622K	Buy	753 +441	+141%	+$367K	0.1%	103
2024 Q4	$241K	Sell	312 -72	-19%	-$59.6K	0.04%	123
2024 Q3	$340K	Sell	384 -5	-1%	-$4.5K	0.05%	114
2024 Q2	$352K	Sell	389 -14	-3%	-$11.2K	0.06%	110
2024 Q1	$314K	Hold	403	–	–	0.05%	111
2023 Q4	$235K	Hold	403	–	–	0.04%	117
2023 Q3	$216K	Buy	+403	New	+$208K	0.04%	114

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Culbertson A N & Co's LLY Position: Q2 2026 in Review

Culbertson A N & Co increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $158K and bringing the position to 1,035 shares worth $1.24M. The position accounts for 0.14% of the portfolio, ranked #94.

Culbertson A N & Co first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Culbertson A N & Co held 1,035 shares of Eli Lilly worth $1.24M as of Q2 2026.
Culbertson A N & Co bought 155 Eli Lilly shares in Q2 2026, an estimated $158K.
Eli Lilly made up 0.14% of Culbertson A N & Co's portfolio in Q2 2026, its #94 holding.
Culbertson A N & Co first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Culbertson A N & Co's 13F filing for Q2 2026, filed 29 Jul 2026.